Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Bengt Glimelius. (2018) Forty-five years in oncology, 25 years with Acta Oncologica. Acta Oncologica 57:12, pages 1593-1598.
Read now
Read now
L. Ø. Poulsen, M. K. Yilmaz, K. Ljungmann, N. Jespersen, P. Wille-Jørgensen, L. N. Petersen & U.G. Falkmer. (2018) Local recurrence rate in a national Danish patient cohort after curative treatment for rectal cancer. Acta Oncologica 57:12, pages 1639-1645.
Read now
Read now
B. Glimelius & A. Martling. (2017) What conclusions can be drawn from the Stockholm III rectal cancer trial in the era of watch and wait?. Acta Oncologica 56:9, pages 1139-1142.
Read now
Read now
Bengt Glimelius. (2017) On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery. Upsala Journal of Medical Sciences 122:1, pages 1-10.
Read now
Read now
Bengt Glimelius. (2016) What is most relevant in preoperative rectal cancer chemoradiotherapy – the chemotherapy, the radiation dose or the timing to surgery?. Acta Oncologica 55:12, pages 1381-1385.
Read now
Read now
Maziar Nikberg, Abbas Chabok, Henry Letocha, Csaba Kindler, Bengt Glimelius & Kenneth Smedh. (2016) Lymphovascular and perineural invasion in stage II rectal cancer: a report from the Swedish colorectal cancer registry. Acta Oncologica 55:12, pages 1418-1424.
Read now
Read now
Luka Stanisavljević, Mette P. Myklebust, Sabine Leh & Olav Dahl. (2016) LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer. Acta Oncologica 55:12, pages 1425-1433.
Read now
Read now
Bengt Glimelius & Nina Cavalli-Björkman. (2016) Does shared decision making exist in oncologic practice?. Acta Oncologica 55:2, pages 125-128.
Read now
Read now
Bengt Glimelius. (2015) What’s new about Acta Oncologica for 2016?. Acta Oncologica 54:10, pages 1703-1705.
Read now
Read now
Cai Grau, Jens Overgaard, Morten Høyer, Kari Tanderup, Jacob Christian Lindegaard & Ludvig Paul Muren. (2015) Biology-guided adaptive radiotherapy (BiGART) is progressing towards clinical reality. Acta Oncologica 54:9, pages 1245-1250.
Read now
Read now
Bengt Glimelius. (2015) Adjuvant chemotherapy for patients with rectal cancer – will the controversy be resolved?. Acta Oncologica 54:4, pages 433-436.
Read now
Read now
Articles from other publishers (24)
妍 向. (2023) Recent Advances in Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer. Advances in Clinical Medicine 13:04, pages 7026-7032.
Crossref
Crossref
C. A. Farzaneh, A. Pigazzi, W. Q. Duong, J. C. Carmichael, M. J. Stamos, F. Dekhordi-Vakil, F. Dayyani, J. A. Zell & M. D. Jafari. (2022) Analysis of delay in adjuvant chemotherapy in locally advanced rectal cancer. Techniques in Coloproctology 27:1, pages 35-42.
Crossref
Crossref
Joseph C Kong, Jennifer Ryan, Timothy Akhurst, Samuel Y Ngan, Michael Michael, Jeanne Tie, Satish K Warrier & Alexander G Heriot. (2021) The predictive value of PET/CT for distant recurrences in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Journal of Medical Imaging and Radiation Oncology 65:7, pages 917-924.
Crossref
Crossref
Camilla Qvortrup & Per Pfeiffer. 2021. Multidisciplinary Treatment of Colorectal Cancer. Multidisciplinary Treatment of Colorectal Cancer
179
182
.
Bengt Glimelius & Erik Osterman. (2020) Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients. Cancers 12:8, pages 2289.
Crossref
Crossref
Bengt Glimelius. (2020) Adjuvant chemotherapy in rectal cancer: state of the art and future perspectives. Current Opinion in Oncology 32:4, pages 377-383.
Crossref
Crossref
Gyoung Tae Noh, Jeonghee Han, Min Soo Cho, Hyuk Hur, Kang Young Lee, Nam Kyu Kim & Byung Soh Min. (2020) The impact of early adjuvant chemotherapy in rectal cancer. PLOS ONE 15:1, pages e0228060.
Crossref
Crossref
Youn Young Park, Kang Young Lee, Nam Kyu Kim, Sat Byol Lee, Ga Ram Kim, Byung Soh Min & Seong-Taek Oh. (2019) Impact of Adjuvant Chemotherapy Completion on Oncologic Outcomes in ypTNMstage 2 Rectal Cancer Patients. Annals of Coloproctology 35:6, pages 335-341.
Crossref
Crossref
Gabriella Buccafusca, Ilaria Proserpio, Antonino Carmelo Tralongo, Sebastiano Rametta Giuliano & Paolo Tralongo. (2019) Early colorectal cancer: diagnosis, treatment and survivorship care. Critical Reviews in Oncology/Hematology 136, pages 20-30.
Crossref
Crossref
Rob Glynne-Jones & Marcia Hall. 2019. Comprehensive Rectal Cancer Care. Comprehensive Rectal Cancer Care
407
444
.
Sepehr Khorasani, Arun Nagarajan, Timothy Nguyen & Sami A. Chadi. 2019. Fundamentals of Anorectal Surgery. Fundamentals of Anorectal Surgery
445
463
.
Xin Wang, Yongyang Yu, Wenjian Meng, Dan Jiang, Xiangbing Deng, Bing Wu, Hua Zhuang, Cun Wang, Yali Shen, Lie Yang, Hong Zhu, Ke Cheng, Yaqin Zhao, Zhiping Li, Memg Qiu, Hongfeng Gou, Feng Bi, Feng Xu, Rrenmin Zhong, Sen Bai, Ziqiang Wang & Zongguang Zhou. (2018) Total neoadjuvant treatment (CAPOX plus radiotherapy) for patients with locally advanced rectal cancer with high risk factors: A phase 2 trial. Radiotherapy and Oncology 129:2, pages 300-305.
Crossref
Crossref
Shang-Jui Wang, Lara Hathout, Usha Malhotra, Nell Maloney-Patel, Sarah Kilic, Elizabeth Poplin & Salma K. Jabbour. (2018) Decision-Making Strategy for Rectal Cancer Management Using Radiation Therapy for Elderly or Comorbid Patients. International Journal of Radiation Oncology*Biology*Physics 100:4, pages 926-944.
Crossref
Crossref
Masoud Babaei, Lina Jansen, Yesilda Balavarca, Annika Sjövall, Amanda Bos, Tony van de Velde, Michel Moreau, Gabriel Liberale, Ana Filipa Gonçalves, Maria José Bento, Cornelia M. Ulrich, Petra Schrotz-King, Valery Lemmens, Bengt Glimelius & Hermann Brenner. (2018) Neoadjuvant Therapy in Rectal Cancer Patients With Clinical Stage II to III Across European Countries: Variations and Outcomes. Clinical Colorectal Cancer 17:1, pages e129-e142.
Crossref
Crossref
Peter Nygren & Bengt Glimelius. 2018. Multidisciplinary Management of Rectal Cancer. Multidisciplinary Management of Rectal Cancer
313
323
.
Carlos Carvalho & Rob Glynne-Jones. (2017) Challenges behind proving efficacy of adjuvant chemotherapy after preoperative chemoradiation for rectal cancer. The Lancet Oncology 18:6, pages e354-e363.
Crossref
Crossref
Manfred P. Lutz, John R. Zalcberg, Rob Glynne-Jones, Theo Ruers, Michel Ducreux, Dirk Arnold, Daniela Aust, Gina Brown, Krzysztof Bujko, Christopher Cunningham, Serge Evrard, Gunnar Folprecht, Jean-Pierre Gerard, Angelita Habr-Gama, Karin Haustermans, Torbjörn Holm, Koert F. Kuhlmann, Florian Lordick, Gilles Mentha, Markus Moehler, Iris D. Nagtegaal, Alessio Pigazzi, Salvatore Pucciarelli, Arnaud Roth, Harm Rutten, Hans-Joachim Schmoll, Halfdan Sorbye, Eric Van Cutsem, Jürgen Weitz & Florian Otto. (2016) Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer. European Journal of Cancer 63, pages 11-24.
Crossref
Crossref
ZHIWEI WANG, XIAOYAN WANG, JIANTIAN LI, CHENG YANG, ZHIYUAN XING, RUIYUN CHEN & FEI XU. (2016) HMGB1 knockdown effectively inhibits the progression of rectal cancer by suppressing HMGB1 expression and promoting apoptosis of rectal cancer cells. Molecular Medicine Reports 14:1, pages 1026-1032.
Crossref
Crossref
Javier Sastre, Juan Jose Serrano, Cristina Fern?ndez, Carmen Ramirez, Luis Ortega, Beatriz Garc?a-Paredes, Juan Corona, Rosario Alfonso, Sof?a C?rdoba & Eduardo D?az-Rubio. (2016) Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine?Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center Series. Clinical Colorectal Cancer 15:2, pages 128-134.
Crossref
Crossref
Mototsugu Matsunaga, Keisuke Miwa, Yosuke Oka, Sachiko Nagasu, Takahiko Sakaue, Masaru Fukahori, Tomoyuki Ushijima & Yoshito Akagi. (2016) mFOLFOX6 Chemotherapy after Resection of Anal Canal Mucinous Adenocarcinoma. Case Reports in Oncology 9:1, pages 280-284.
Crossref
Crossref
Suzanne Russo, Scott Steele, Elisha Fredman & Tithi Biswas. (2016) Current topics in the multimodality treatment of locally advanced rectal cancer. Future Oncology 12:7, pages 963-979.
Crossref
Crossref
J. Boustani, M. Caubet & J.-F. Bosset. (2016) Adjuvant Chemotherapy in Rectal Cancer after Chemoradiotherapy. Clinical Oncology 28:2, pages 140-145.
Crossref
Crossref
Eiji Oki, Koji Ando, Yuta Kasagi, Yoko Zaitsu, Masahiko Sugiyama, Yuichiro Nakashima, Hideto Sonoda, Kippei Ohgaki, Hiroshi Saeki & Yoshihiko Maehara. (2015) Recent advances in multidisciplinary approach for rectal cancer. International Journal of Clinical Oncology 20:4, pages 641-649.
Crossref
Crossref
K. Bujko, B. Glimelius, V. Valentini, W. Michalski & M. Spalek. (2015) Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: A meta-analysis of randomized trials comparing surgery???a fluoropyrimidine and surgery?+?a fluoropyrimidine???oxaliplatin. European Journal of Surgical Oncology (EJSO) 41:6, pages 713-723.
Crossref
Crossref